STEMCELL Technologies Inc. is a privately-owned biotechnology company based in Vancouver that helps power leading-edge life sciences research around the world. Scientists performing stem cell, immunology, cancer, regenerative medicine and cellular therapy research are among those who rely on our cell culture media, cell separation products, instruments, ancillary reagents and contract assay services. We create novel, useful, standardized products of unfailing quality and deliver them to more than 70 countries via our many regional offices plus distribution centers in Vancouver, Seattle, Grenoble and Singapore. Driven by our love of science and our passion for quality, we see ourselves simply as "Scientists Helping Scientists" – standing by our customers to provide outstanding products, technical support and training. We have approximately 500 science-oriented employees globally, including 100 PhDs/MScs, with most others holding a BSc or engineering degree.
STEMCELL has leadership presence in the Europe ancillary reagent markets, delivering excellent sales and service support to the European customers. STEMCELL has also developed high-quality automated platforms with the needs of customers in mind and that are supported through our warranties, on-site service and software updates:
RoboSepâ„¢-S for fully automated isolation of immune and hematopoietic cells
ClonaCellâ„¢ EasyPick for automated colony picking during cell line development
STEMvisionâ„¢ for automated colony counting in hematopoietic colony-forming unit (CFU) assays.
